From Financial Modeling Prep: 2025-04-29 04:05:00

In summary, Novartis AG (NYSE:NVS) reported an EPS of $2.28, exceeding expectations, with revenue slightly below estimates at $13.23 billion. The company raised its 2025 financial outlook after a 23% increase in core operating profit, driven by strong drug demand. Financial metrics indicate a healthy market position, with moderate debt levels and positive short-term financial health.



Read more at Financial Modeling Prep:: Novartis AG (NYSE:NVS) Surpasses Earnings Estimate…